https://medicaldialogues.in/nephrology/news/sglt2-inhibitors-lower-chronic-kidney-disease-risk-in-diabetes-patients-with-higher-dcsi-study-104442
Taiwan: The use of sodium-glucose cotransporter-2 inhibitors (SGLT2Is) significantly lowers the risk of chronic kidney disease (CKD) in type 2 diabetes patients with a higher DCSI (diabetes...
Create an account or login to join the discussion